01 8INDIVIOR
01 89782402
01 8Blank
01 8Y
01 82031-06-06
Patent Expiration Date : 2031-06-06
US Patent Number : 9782402
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209819
Patent Use Code : U-2176
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-06-06
Patent Expiration Date : 2031-06-06
US Patent Number : 9782402
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209819
Patent Use Code : U-2208
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-06-06
Patent Expiration Date : 2031-06-06
US Patent Number : 9782402
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209819
Patent Use Code : U-2180
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-06-06
Patent Expiration Date : 2031-06-06
US Patent Number : 9782402
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209819
Patent Use Code : U-2207
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-06-06
Patent Expiration Date : 2031-06-06
US Patent Number : 9782402
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209819
Patent Use Code : U-2176
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-06-06
Patent Expiration Date : 2031-06-06
US Patent Number : 9782402
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209819
Patent Use Code : U-2207
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-06-06
Patent Expiration Date : 2031-06-06
US Patent Number : 9782402
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209819
Patent Use Code : U-2180
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-06-06
Patent Expiration Date : 2031-06-06
US Patent Number : 9782402
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209819
Patent Use Code : U-2208
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-06-06
